A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy

Name: A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy
Published: 2017
License: Public Domain

Sumitomo Pharma America, Inc. · 2017

ClinicalTrials.gov · Datasets · License: Public Domain · 2017

Open Source ↗

brain-cancer brain-tumor glioblastoma glioma neoplasms

glioblastoma, glioblastoma (gbm), wilms tumor 1 (wt1), cancer vaccines, neoplasms, astrocytoma, glioma, brain cancer, brain tumor, bevacizumab, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy

Related documents